Plasminogen Activator Inhibitor-1 (PAI-1) is an Essential Driver of Cardiovascular Aging in Mice

被引：0
作者：
Kalousdian, Anthony
Soberanes, Saul
Eren, Mesut
Jorgensen, Emily
Lux, Elizabeth
Wilsbacher, Lisa D.
Vaughan, Douglas E.
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
Aging; Cardiovascular disease; Hypertension; Blood pressure; Cardiovascular Risk;
D O I：
10.1161/circ.148.suppl_1.14009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A14009
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The moderating effect of personal mastery on the relations between stress and plasminogen activator inhibitor-1 (PAI-1) antigen
    Mausbach, Brent T.
    Patterson, Thomas L.
    von Kaenel, Roland
    Dimsdale, Joel E.
    Depp, Colin A.
    Aschbacher, Kirstin
    Mills, Paul J.
    Ancoli-Israel, Sonia
    Grant, Igor
    HEALTH PSYCHOLOGY, 2008, 27 (02) : S172 - S179
  • [2] Role of Plasminogen Activator Inhibitor-1 in Senescence and Aging
    Eren, Mesut
    Boe, Amanda E.
    Klyachko, Ekaterina A.
    Vaughan, Douglas E.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2014, 40 (06) : 645 - 651
  • [3] Subcutaneous adipose tissue expression of plasminogen activator inhibitor-1 (PAI-1) in nondiabetic and Type 2 diabetic subjects
    Koistinen, HA
    Dusserre, E
    Ebeling, P
    Vallier, P
    Koivisto, VA
    Vidal, H
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2000, 16 (05) : 364 - 369
  • [4] Plasminogen Activator Inhibitor-1 (PAI-1): A Key Factor Linking Fibrinolysis and Age-Related Subclinical and Clinical Conditions
    Cesari, Matteo
    Pahor, Marco
    Incalzi, Raffaele Antonelli
    CARDIOVASCULAR THERAPEUTICS, 2010, 28 (05) : e72 - e91
  • [5] Effects of perindopril treatment on hemostatic function in patients with essential hypertension in relation to angiotensin converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) gene polymorphisms
    Jastrzebska, M
    Widecka, K
    Naruszewicz, M
    Ciechanowicz, A
    Janczak-Bazan, A
    Foltynska, A
    Goracy, I
    Chetstowski, K
    Wesotowska, T
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2004, 14 (05) : 259 - 269
  • [6] Polymorphism and synergism of angiotensin-converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) genes in coronary artery disease
    Sakhteh, Maryam
    Poopak, Behzad
    Amirizadeh, Naser
    Shamshiri, Ahmadreza
    Bagheri, Abdolhamid
    Faranoush, Mohammad
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2015, 16 (04) : 1168 - 1174
  • [7] Effects of Altered Plasminogen Activator Inhibitor-1 Expression on Cardiovascular Disease
    Ploplis, Victoria A.
    CURRENT DRUG TARGETS, 2011, 12 (12) : 1782 - 1789
  • [8] Effects of short-term exercise training on plasminogen activator inhibitor (PAI-1)
    Bodary, PF
    Yasuda, N
    Watson, DD
    Brown, AS
    Davis, JM
    Pate, RR
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2003, 35 (11) : 1853 - 1858
  • [9] Plasminogen activator inhibitor-1 and haemostasis in obesity
    Mutch, NJ
    Wilson, HM
    Booth, NA
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2001, 60 (03) : 341 - 347
  • [10] Role of plasminogen activator inhibitor-1 in coronary pathophysiology
    Jung, Richard G.
    Simard, Trevor
    Labinaz, Alisha
    Ramirez, F. Daniel
    Di Santo, Pietro
    Motazedian, Pouya
    Rochman, Rebecca
    Gaudet, Chantal
    Faraz, Mohammad Ali
    Beanlands, Rob S. B.
    Hibbert, Benjamin
    THROMBOSIS RESEARCH, 2018, 164 : 54 - 62
12345